ArticleBritish journal of cancer2024

Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.

Michael D Hogarty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.